Community post

Several high-profile phage therapy clinical trials have failed, leading many to point toward phage formulation and method of application as being of underappreciated importance. Daniel Rosner (Fixed Phage, Glasgow) and colleagues published a new review in Pharmaceuticals on formulations for phage therapy and potential uses of phage immobilization.